{
  "pmcid": "8493003",
  "sha256": "fb88f9c5d18cab88ab634252f20f002f8a577c4a15b00b7c054d2daec66d9134",
  "timestamp_utc": "2025-11-09T16:18:00.081976+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.264081098757362,
    "reading_ease": 43.98103335513409,
    "word_count": 278
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients with newly diagnosed breast cancer were randomized to either preoperative MRI or conventional imaging."
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with newly diagnosed breast cancer were randomized to either preoperative MRI or conventional imaging."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients with newly diagnosed breast cancer were randomized to either preoperative MRI or conventional imaging."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "evaluating MRI and its effect on disease-free survival (DFS) and overall survival (OS)."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 440 patients, aged 56 years or less, with newly diagnosed breast cancer were randomized to either preoperative MRI (220) or conventional imaging (220; control)."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "DFS rates were 85.5 and 80.0 per cent for the MRI and control groups respectively ( P = 0.099). The risk of relapse or death was 46 per cent higher in the control group (HR 1.46, 95 per cent c.i. 0.93 to 2.29)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Registration number: NCT01859936 ( http://www.clinicaltrials.gov )."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}